Health-related quality of life, mental distress und somatopsychic symptoms in adult patients with haematological neoplasms

Health-related quality of life, mental distress und somatopsychic symptoms in adult patients with haematological neoplasms - PSY-HAEM-ONC

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003453

Enrollment

500

Registered

2011-12-27

Start date

2006-09-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C92.0 C82.2

Interventions

Group 1: Longitudinal assessment of described patient-reported outcomes: T1-at beginning of cancer treatment, T2-interim staging according to the chemotherapy protocol, T3-last discharge after treatme

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: ICD-10-C-diagnosis, ECOG < 3

Exclusion criteria

Exclusion criteria: palliative treatment, ECOG > 2

Design outcomes

Primary

Measure	Time frame
a. Validation of the Somatic Burden Score SBS-AE b. Aspects of mental health and somatopsychic symptoms in patients with haematological malignoms (e.g., general health perception, fatigue) assessed with the Medical Outcomes Study 36-Item Short Form Survey Instrument (SF-36), Patient Health Questionnaire (PHQ-D), Brief COPE and scale of general self-efficacy as longitudinal investigation: T1-at beginning of cancer treatment, T2-interim staging according to the chemotherapy protocol, T3-last discharge after treatment.	—

Measure

Time frame

a. Validation of the Somatic Burden Score SBS-AE b. Aspects of mental health and somatopsychic symptoms in patients with haematological malignoms (e.g., general health perception, fatigue) assessed with the Medical Outcomes Study 36-Item Short Form Survey Instrument (SF-36), Patient Health Questionnaire (PHQ-D), Brief COPE and scale of general self-efficacy as longitudinal investigation: T1-at beginning of cancer treatment, T2-interim staging according to the chemotherapy protocol, T3-last discharge after treatment.

—

Secondary

Measure	Time frame
associations between the somatic burden of chemotherapy induced adverse events and mental distress outcomes of cancer patients.	—

Countries

Germany

Contacts

Public ContactMichael Koehler

Universitätsklinik für Hämatologie und Onkologie

michael.koehler@med.ovgu.de+49 (0) 391-67-13307

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 20, 2026